Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-25T20:50:04.829Z Has data issue: false hasContentIssue false
  • English
  • Français

Vancomycin-Intermediate Staphylococcus epidermidis: Curio or Omen?

Published online by Cambridge University Press:  02 January 2015

Larry J. Strausbaugh
Larry J. Strausbaugh*
Affiliation:
Infectious Disease Section, Medical Service, Veterans' Affairs Medical Center; Division of Infectious Diseases, Department of Medicine, School of Medicine, Oregon Health Sciences University, Portland, Oregon
*
Medical Service (P-3-ID), Veterans'Affairs Medical Center, PO Box 1034, Portland, OR 97207
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 3 , March 1999 , pp. 163 - 165
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

References

1. Garrett, DO, Jochimsen, E, Murfitt, K, Hill, B, McAllister, S, Nelson, P, et al. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis . Infect Control Hosp Epidemiol 1999;20:167–170.CrossRefGoogle ScholarPubMed
2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Eighth Informational Supplement. NCCLS document M100-S8. Wayne, PA NCCLS; 1998.Google Scholar
3. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. MMWR 1997;46:765–766.Google Scholar
4. Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. MMWR 1997;46:813–815.Google Scholar
5. Sanyal, D, Johnson, AP, George, RC, Cookson, BD, Williams, AJ. Peritonitis due to vancomycin-resistant Staphylococcus epidermidis . Lancet 1991;337:54.CrossRefGoogle ScholarPubMed
6. Sanyal, D, Johnson, AP, George, RC, Edwards, R, Greenwood, D. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD. J Antimicrob Chemother 1993;32:267–278.CrossRefGoogle ScholarPubMed
7. Krcmery, V Jr, Trupl, J, Drgona, L, Lacka, J, Kukuckova, E, Oravcova, E. Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin. Eur J Clin Microbiol Infect Dis 1996;15:259–261.CrossRefGoogle ScholarPubMed
8. Hiramatsu, K, Hanaki, H, Ino, T, Yabuta, K, Oguri, T, Tenover, FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135–136.CrossRefGoogle ScholarPubMed
9. Rotun, SS, McMath, V, Schoonmaker, DJ, Maupin, PS, Tenover, FC, Hill, BC, et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerging Infectious Diseases. In press.Google Scholar
10. Froggatt, JW, Johnston, JL, Gaietto, DW, Archer, GL. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus . Antimicrob Agents Chemother 1989;33:460–466.CrossRefGoogle ScholarPubMed
11. Schwalbe, RS, Stapleton, JT, Gilligan, PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987;316:927–931.CrossRefGoogle ScholarPubMed
12. Veach, LA, Pfaller, MA, Barrett, M, Koontz, FP, Wenzel, RP. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 1990;28:2064–2068.CrossRefGoogle ScholarPubMed
13. Schwalbe, RS, Ritz, WJ, Verma, PR, Barranco, EA, Gilligan, PH. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus . J Infect Dis 1990;161:45–51.CrossRefGoogle ScholarPubMed
14. Archer, GL, Climo, MW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 1994;38:2231–2237.CrossRefGoogle ScholarPubMed
15. Goldstein, FW, Coutrot, A, Sieffer, A, Acar, JF. Percentages and distribution of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother 1990;34:899–900.CrossRefGoogle ScholarPubMed
16. Maugein, J, Pellegrin, JL, Brassard, G, Fourche, J, Leng, B, Reiffers, J. In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients. Antimicrob Agents Chemother 1990;34:901–903.CrossRefGoogle ScholarPubMed
17. Bannerman, TL, Wadiak, DL, Kloos, WE. Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob Agents Chemother 1991;35:1919–1922.CrossRefGoogle ScholarPubMed
18. Sieradzki, K, Villari, P, Tomasz, A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 1998;42:100–107.CrossRefGoogle ScholarPubMed
19. Gruneberg, RN. Anti-gram-positive agents—what we have and what we would like. Drugs 1997;54(suppl)6:29–38.CrossRefGoogle Scholar
20. Kaatz, GW, Seo, SM, Dorman, NJ, Lerner, SA. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus . J Infect Dis 1990;162:103–108.CrossRefGoogle ScholarPubMed
21. Tenover, FC, Lancaster, MV, Hill, BC, Steward, CD, Stocker, SA, Hancock, GA, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998;36: 1020–1027.CrossRefGoogle ScholarPubMed
22. Shlaes, DM, Shlaes, JH, Vincent, S, Etter, L, Fey, PD, Goering, RV. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob Agents Chemother 1993;37:2432–2437.CrossRefGoogle ScholarPubMed
23. Shlaes, DM, Shlaes, JH. Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin. Clin Infect Dis 1995;20:1071–1073.CrossRefGoogle ScholarPubMed
24. Moreira, B, Boyle-Vavra, S, dejonge, BLM, Daum, RS. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus . Antimicrob Agents Chemother 1997;41:1788–1793.CrossRefGoogle ScholarPubMed
25. Sanyal, D, Greenwood, D. An electronmicroscope study of glycopeptide antibiotic-resistant strains of Staphylococcus epidermidis . J Med Microbiol 1993;39:204–210.CrossRefGoogle ScholarPubMed
26. Kernodle, DS, Barg, NL, Kaiser, AB. Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organism during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother 1988;32:202–208.CrossRefGoogle ScholarPubMed